Rivus to show animal data on muscle-sparing GLP-1
The preclinical results for RV-8451, an oral GLP-1 pill, will go on display as three posters at ObesityWeek in Washington, DC, in November. If you sat down to write a wish list for a weight-loss drug, a pill that goes after fat and leaves muscle alone would probably land near the top. Rivus Pharmace
<p>The preclinical results for RV-8451, an oral GLP-1 pill, will go on display as three posters at ObesityWeek in Washington, DC, in November. If you sat down to write a wish list for a weight-loss drug, a pill that goes after fat and leaves muscle alone would probably land near the top. Rivus Pharmace</p>